HOLMES CRISPR diagnostics market to hit $5.8b by 2033

However, regulatory hurdles and data standardisation remain key challenges.

The global HOLMES CRISPR diagnostics market is expected to reach $5.8b by 2033 at a compound annual growth rate of 19.2%, said Research Intelo.

The sector is primarily driven by the increasing demand for rapid, accurate, and cost-effective diagnostic solutions amidst the rising prevalence of infectious and genetic diseases.

“The HOLMES system continues to evolve through integration with microfluidics, nanotechnology, and digital detection platforms,” the report said.

However, regulatory hurdles, scalability and reproducibility in mass manufacturing, and data standardisation remain key challenges to market growth.